Reduction of Pulmonary Arterial Hypertension (Pah)-Related Hospitalizations With Macitentan in the Randomized Controlled Trial Seraphin
Value in Health - United Kingdom
doi 10.1016/j.jval.2013.03.1175
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2013
Authors
Publisher
Elsevier BV